Q301--Cytopathology and Next Generation Sequencing Testing

The Department of Veterans Affairs Network Contracting Office 2 is soliciting offers to establish an Indefinite Delivery Indefinite Quantity (IDIQ) contract for comprehensive molecular diagnostic testing using next-generation sequencing to evaluate thyroid nodules with indeterminate fine-needle aspiration cytology. The goal is to improve clinical decision-making by providing scientifically validated genomic insights that enhance diagnostic accuracy, reduce the incidence of unnecessary surgical interventions, and enable timely, personalized care for Veterans at risk. This contract will support the delivery of clinically integrated testing services that align with evolving standards in cytopathology and molecular diagnostics. The solicitation, numbered 36C24226Q0875, was posted on August 4, 2026, with proposals due by August 21, 2026, and is classified under NAICS code 621511 for medical and diagnostic laboratories. Offerors must be prepared to perform services primarily at the Northport, New York location, with the contracting office located in Albany, New York. The primary point of contact is Contracting Officer Mariangie Rivera, reachable via email at Mariangie.Rivera@va.gov. This procurement is structured as a combined solicitation and does not specify a small business set-aside, indicating open competition across eligible industry participants seeking to provide advanced molecular testing solutions to the Veterans Health Administration.